| abstract |
This invention relates to the use of nucleic acid and amino acid sequences of Optic atrophy 1 protein, cornichon-like, IGF-II mRNA-binding protein 3, neuralized-like, KIAA1094 protein, casein kinase (delta and epsilon), glutamate dehydrogenase, kraken homolog, sirtuin 1, escargot homolog, human KIAA1585 protein, CG11940 homolog, dappled homolog, CG11753 homolog, human KIAA0095 protein, formin-binding protein 21, and/or homologous proteins in pharmaceutical compositions, and to the use of these sequences in the diagnosis, study, prevention, and treatment of diseases and disorders related to body-weight regulation and thermogenesis. |